This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Warner-Lambert Company. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Inventor Spotlight: Jeffrey D. Scholten
Introduction
Jeffrey D. Scholten is a notable inventor based in Brighton, MI, who has made significant contributions in the field of biochemistry and pharmaceuticals. With a total of two patents to his name, Scholten's work showcases his innovative approach to solving complex problems in medical science.
Latest Patents
Scholten's latest patents include "Substituted dinaphthylmethyl and diheteroarylmethylacetyl histidine" and "Tricyclic inhibitors of protein farnesyltransferase." These inventions underline his focus on developing compounds that have potential therapeutic applications, particularly in targeting protein farnesyltransferase, which plays a role in various diseases.
Career Highlights
Jeffrey D. Scholten is associated with Warner-Lambert Company, where he has been instrumental in advancing research in pharmaceutical innovations. His work is characterized by a commitment to enhancing therapeutic options and contributing to the overall health and well-being of patients.
Collaborations
Throughout his career, Scholten has collaborated with talented professionals including Annette M. Doherty and James S. Kaltenbronn. These partnerships have facilitated the exchange of ideas and have led to productive research outcomes, showcasing the importance of teamwork in the field of innovation.
Conclusion
In conclusion, Jeffrey D. Scholten stands out as a pioneering inventor whose work continues to influence the pharmaceutical industry. His patents demonstrate a clear dedication to innovation and research, paving the way for future advancements in medical therapeutics.